Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.100130
Revised: September 19, 2024
Accepted: September 27, 2024
Published online: January 27, 2025
Processing time: 129 Days and 4.4 Hours
The diagnosis of gastric carcinoma (GC) is essential for improving clinical outcomes. However, the biomarkers currently used for GC screening are not ideal.
To explore the diagnostic implications of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammatory index (SII) for GC.
The baseline data of 133 patients with GC and 134 patients with precancerous gastric conditions admitted between January 2022 and December 2023 were retrospectively analyzed. The information on peripheral blood platelet, neutro
The data indicated that NLR, PLR, and SII had abnormally increased levels in the patients with GC. Gender and body mass index were risk factors for the occurrence of GC. ROC data revealed that the areas under the curve of three patients with precancerous gastric conditions, who were differentiated from those with GC, were 0.824, 0.787, and 0.842, respectively.
NLR, PLR, and SII are all abnormally expressed in GC and have diagnostic implications, especially when used as joint indicators, in distinguishing patients with precancerous gastric conditions from those with GC.
Core Tip: This study included 133 patients with gastric carcinoma (GC) and 134 with precancerous gastric conditions. Routine peripheral blood information of these patients was collected, and the systemic immune-inflammatory index (SII), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) levels in both groups were calculated and compared. In-depth analysis confirmed that NLR, PLR, and SII exhibited abnormally increased levels in GC and, therefore, had diagnostic significance for distinguishing patients with precancerous gastric conditions from those with GC. Additionally, multivariate logistic regression analysis confirmed that gender and body mass index were risk factors for the occurrence of GC. The findings can provide convenient, low-cost, and highly efficient biological indicators for screening for early GC, as well as more clinical evidence and references for the prevention and management of early GC.